Heart and nervous system health after stem cell transplant
Part of Immune system & allergy clinical trials.
This study looks at how your autonomic nervous system (the part that controls heartbeat and digestion) affects the risk of graft-versus-host disease (a condition where donor cells attack your body) after a half-matched stem cell transplant. You may be able to join if you are older than 16 and receiving a half-matched transplant from a family donor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 16 years old.
- You are getting a stem cell transplant from a half-matched family donor (haploidentical).
- You agree to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special score (immune risk score) to check how well your immune system rebuilds after a half-matched stem cell transplant. The goal is to find patients who might need extra help with immune recovery.
This study follows patients who have had a stem cell transplant to see how their heart and blood vessels are doing over time. It helps doctors learn about long-term heart risks after transplant.
This trial tests whether a special probiotic made from the patient's own gut bacteria and their donor's can help fix gut problems caused by a complication called graft-versus-host disease (aGVHD) after a stem cell transplant. It might help patients who are over 50 and scheduled for a specific type of transplant.
This study looks at whether a special health evaluation designed for older adults can help doctors better plan stem cell transplants for people 55 and older with blood disorders. You would receive a series of questionnaires and tests to assess your overall health before transplant.
This study looks at heart problems that can happen after a stem cell transplant from a donor (allogeneic). It aims to understand these risks better so doctors can help patients stay healthier after transplant.
This study looks at special immune cells in the body that may be involved in graft-versus-host disease (GVHD), a complication after a stem cell transplant. The goal is to better understand these cells to improve future treatments for GVHD.
Hear when a new Transplant-Related Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.